Rheumatology International

, Volume 13, Issue 2, pp 61–64 | Cite as

Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo

  • D. J. Francis
  • N. Hutadilok
  • P. Kongtawelert
  • P. Ghosh


Pentosan polysulphate (PPS) and glycosaminoglycan polysulphate (GAGPS) were examined for their ability to alter hyaluronan synthesis in vivo. The inflamed rat subcutaneous ari pousch model was used for the study. PPS or GAGPS injected into the air pouch at a dose of 2.5 mg/kg daily for 7 days resulted in higher molecular weight hyaluronan in the pouch fluid compared with control non-drug-treated pouch fluid. The quantity of the hyaluronan was increased by PPS, but not by GAGPS. We concluded that both drugs could be beneficial in the treatment of inflammatory arthritides in which a decrease in normal synovial hyaluronan concentration and molecular weight occurs.

Key words

Pentosan polysulphate Glycosaminoglycan polysulphate Hyaluronan Air pouch model 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Radin EL, Paul IL (1972) A consolidated concept of joint lubrication. J Bone Joint Surg 54A:607–616Google Scholar
  2. 2.
    Langer HE, Altman S, Lührs W, Zeidler H (1987) The lubrication of the natural joint: Viscosity of hyaluronic acid and friction in the human hip. In: Bergmann G, Kölbel R, Rohlmann A, Nijhoff M (eds) Biomechanics 1986. Selected proceedings of the fifth meeting of the European Society of Biomechanics. OordrechtGoogle Scholar
  3. 3.
    Balazs EA, Watson D, Duff IF, Roseman S (1976) Hyaluronic acid in synovial fluid. I. Molecular parameters of hyaluronic acid in normal and arthritic human fluids. Arthritis Rheum 10:357–375Google Scholar
  4. 4.
    Dahl LB, Dahl IMS, Engstrom-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817–822Google Scholar
  5. 5.
    Brandt K (1970) Modification of chemotaxis by synovial fluid hyaluronate. Arthritis Rheum 13:308–309Google Scholar
  6. 6.
    Pisko EJ, Turner RA, Soderstom LP, Panetti M, Foster SL, Treadway WJ (1983) Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1:41–44Google Scholar
  7. 7.
    Håkansson L, Hällgren R, Venge P (1980) Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest 66:298–305Google Scholar
  8. 8.
    Sato H, Takahashi T, Ide H, Fukushima T, Tabata M, Sekine F, Kobayashi K, Negishi M, Niwa Y (1988) Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Synovial fluid scavenging effect is enhanced in rheumatoid arthritis patients. Arthritis Rheum 31:63–71Google Scholar
  9. 9.
    Goldberg RL, Toole PB (1987) Hyaluronate inhibition of cell profileration. Arthritis Rheum 30:769–778Google Scholar
  10. 10.
    Smith MM, Ghosh P (1986) The effects of some polysulphated polysaccharides on hyaluronate (HA) synthesis by human synovial fibroblasts. Agents Actions 18 [Suppl]:55–62Google Scholar
  11. 11.
    Hutadilok N, Smith MM, Cullis-Hill D, Brooks PM, Ghosh P (1988) Pentosan polysulphate stimulates hyaluronate and DNA synthesis in synovial fibroblasts and partially reduces the suppressive effect of hydrocortisone on fibroblast metabolism. Curr Ther Res 44:845–860Google Scholar
  12. 12.
    Nishikawa H, Mori I, Umemoto J (1988) Glycosaminoglycan polysulfate-induced stimulation of hyaluronic acid synthesis in rabbit knee synovial membrane: Involvement of binding protein and calcium ion. Arch Biochem Biophys 266:201–209Google Scholar
  13. 13.
    Verbruggen G, Veys EM (1992) Intra-articular injection of pentosan polysulphate results in increased hyaluronan molecular weight in joint fluid. Clin Exp Rheumatol 10:249–254Google Scholar
  14. 14.
    Carreno MR, Muniz OE, Howell DS (1986) The effect of glycosaminoglycan polysulfuric acid ester on articular cartilage in experimental osteoarthritis: Effects on morphological variables of disease severity. J. Rheumatol 13:490–497Google Scholar
  15. 15.
    Hannan N, Ghosh P, Bellenger C, Taylor T (1987) Systemic administration of glycosaminoglycan polysulphate (Arteparon®) provides partial protection of articular cartilage from damage produced by menisectomy in the canine. J Orthop Res 5:47–59Google Scholar
  16. 16.
    Howell DS, Carreno MR, Pelletier J-P, Muniz OE (1986) Articular cartilage breakdown in a lapine model of osteoarthritis: action of glycosaminoglycan polysulfate ester (GAGPS) on proteoglycan degrading enzyme activity, hexuronate, and cell counts. Clin Orthop 213:69–76Google Scholar
  17. 17.
    Golding JC, Ghosh P (1983) Drugs for osteoarthrosis I: the effects of pentosan polysulphate (SP54) on the degradation and loss of proteoglycans from articular cartilage in a model of osteoarthritis induced in the rabbit knee joint by immobilization. Curr Ther Res 33:173–184Google Scholar
  18. 18.
    Francis DJ, Forrest MJ, Brooks PM, Ghosh P (1989) Retardation of articular cartilage degradation by glycosaminoglycan polysulfate, pentosan polysulfate, and DH-40J in the rat air pouch model. Arthritis Rheum 32:608–616Google Scholar
  19. 19.
    Jones IL, Sandström T (1985) Enhanced breakdown of bovine articular cartilage proteoglycans by conditioned synovial medium in vitro. The effect of glycosaminoglycan polysulfate. Arzneimittelforschung 35:141–144Google Scholar
  20. 20.
    Edwards JCW, Sedgwick AD, Willoughby DA (1981) The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J pathol 134:147–156Google Scholar
  21. 21.
    Kowanko IC, Gordon TP, Rozenbilds MAM, Brooks PM, Roberts-Thomson PJ (1986) The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agents Actions 18:421–428Google Scholar
  22. 22.
    Burkhardt D, Ghosh P (1987) Laboratory evaluation of antiarthritic drugs as potential chondroprotecive agents. Semin Arthritis Rheum 17[Suppl 1]:3–34Google Scholar
  23. 23.
    Kongtawelert P, Ghosh P (1989) An enzyme-linked immunosorbent-inhibition assay for quantitation of hyaluronan (hyaluronic acid) in biological fluids. Anal Biochem 178:367–371Google Scholar
  24. 24.
    Verbruggen G, Veys EM (1977) Influence of sulphated glycosaminoglycans upon proteoglycan metabolism of the synovial cell lining. Acta Rheumatol Belg 1:75–92Google Scholar
  25. 25.
    Verbruggen G, Veys WM, Luyten FP, Suykens S (1981) Some “antiarthritic” properties of an oversulphated glycosaminoglycan in degenerative joint disease. In: Inflammation: mechanisms and treatment. Willoughby DA, Giroud JP (eds) MRP Press, Lancaster, Boston, The Hague, Dordrecht, pp 183–191Google Scholar
  26. 26.
    Nishikawa H, Mori H, Umemoto I (1985) Influence of sulfated glycosaminoglycans on the biosynthesis of hyaluronic acid in rabbit knee synovial membrane. Arch Biochem Biophys 240:146–153Google Scholar
  27. 27.
    Stephens RW, Ghosh P, Taylor TKF (1975) The characterisation and function of the polysaccharidases of human synovial fluid in rheumatoid and osteoarthritis. Biochem Biophys Acta 399:101–112Google Scholar
  28. 28.
    Greenwald RA, Moy WW (1980) Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum 23:455–463Google Scholar
  29. 29.
    Kulonen E, Mäkasara P, Seppälä P, Näntö V (1966) Physiochemical properties of synovial fluid with reference to rheumatoid disease and the effect of hydrocortisone treatment. Fed Proc 25:1141–1143Google Scholar
  30. 30.
    Baici A, Salgam P, Fehr K, Böni A (1980) Inhibition of human elastase from polymorphonuclear leucocytes by a glycosaminoglycan polysulfate (Arteparon®). Biochem Pharmacol 29:1723–1727Google Scholar
  31. 31.
    Baici A, Salgam P, Fehr K, Böni A (1981) Inhibition of human elastase from polymorphonuclear leucocytes by gold thiomalate and pentosan polysulphate. Biochem Pharmacol 30:703–708Google Scholar
  32. 32.
    Andrews JL, Ghosh P, Lentini A, ternai B (1983) The interaction of pentosan polysulphate (SP54) with human neutrophil elastase and connective tissue matrix components. Chem Biol Interact 47:157–173Google Scholar
  33. 33.
    Walton EA, Upfold LI, Stephenson RW, Ghosh P, Taylor TKF (1981) Nonsteroidal antiinflammatory drugs (NSAIDs) and articular cartilage integrity. Semin Arthritis Rheum 11 [Suppl 1]: 147–149Google Scholar
  34. 34.
    Buddecke E, Platt D (1965) Untersuchungen zur Chemie der Arterienwand, VIII. Nachweis, Reinigung und Eigenschaften der Hyaluronidase aus der Aorta des Rindes. Hoppe-Seylers Z Physiol Chem 343:61–79Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • D. J. Francis
    • 1
    • 2
  • N. Hutadilok
    • 1
  • P. Kongtawelert
    • 1
  • P. Ghosh
    • 1
  1. 1.Raymond Purves Research LaboratoriesThe University of Sydney, The Royal North Shore HospitalSt. LeonardsAustralia
  2. 2.Department of RheumatologyThe Royal North Shore HospitalSt. LeonardsAustralia

Personalised recommendations